NYSE:DHR - Danaher Stock Price, Price Target & More

Get Started

$102.29 -0.03 (-0.03 %)

(As of 05/24/2018 04:00 PM ET)

Previous Close$102.29

Today's Range$101.88 - $103.13

52-Week Range$78.97 - $104.82

Volume1.31 million shs

Average Volume2.41 million shs

Market Capitalization$70.84 billion

P/E Ratio25.38

Dividend Yield0.63%

Beta1.03

About Danaher (NYSE:DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The company offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. This segment offers implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for packaging, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Process control instruments

Sub-IndustryIndustrial Conglomerates

SectorMulti-Sector Conglomerates

SymbolNYSE:DHR

CUSIP23585110

Webwww.danaher.com

Phone202-828-0850

Debt

Debt-to-Equity Ratio0.38

Current Ratio1.59

Quick Ratio1.15

Price-To-Earnings

Trailing P/E Ratio25.38

Forward P/E Ratio22.99

P/E Growth1.9

Sales & Book Value

Annual Sales$18.33 billion

Price / Sales3.90

Cash Flow$5.9196 per share

Price / Cash17.28

Book Value$38.94 per share

Price / Book2.63

Profitability

EPS (Most Recent Fiscal Year)$4.03

Net Income$2.49 billion

Net Margins13.56%

Return on Equity11.39%

Return on Assets6.36%

Miscellaneous

Employees67,000

Outstanding Shares698,570,000

Danaher (NYSE:DHR) Frequently Asked Questions

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher announced a quarterly dividend on Tuesday, May 8th. Investors of record on Friday, June 29th will be given a dividend of $0.16 per share on Friday, July 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.63%. The ex-dividend date is Thursday, June 28th. View Danaher's Dividend History.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) issued its quarterly earnings results on Thursday, April, 19th. The conglomerate reported $0.99 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.94 by $0.05. The conglomerate earned $4.70 billion during the quarter, compared to the consensus estimate of $4.54 billion. Danaher had a return on equity of 11.39% and a net margin of 13.56%. The firm's quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.85 earnings per share. View Danaher's Earnings History.

When is Danaher's next earnings date?

Danaher is scheduled to release their next quarterly earnings announcement on Thursday, July, 19th 2018. View Earnings Estimates for Danaher.

What guidance has Danaher issued on next quarter's earnings?

Danaher updated its FY18 earnings guidance on Thursday, April, 19th. The company provided earnings per share guidance of $4.38-4.48 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.41. Danaher also updated its Q2 guidance to $1.07-1.10 EPS.

What price target have analysts set for DHR?

17 analysts have issued twelve-month price objectives for Danaher's shares. Their forecasts range from $83.00 to $117.00. On average, they expect Danaher's share price to reach $105.0647 in the next year. View Analyst Ratings for Danaher.

Who are some of Danaher's key competitors?

Some companies that are related to Danaher include Roper Technologies (ROP), Fortive (FTV), Keysight (KEYS), Sensata Technologies (ST), Cognex (CGNX), MKS Instruments (MKSI), Orbotech (ORBK), Esterline (ESL), Rudolph Technologies (RTEC), Mesa Laboratories (MLAB), Hurco Companies (HURC), Universal Detection Technology (UNDT), Clearsign Combustion (CLIR), International Isotopes (INIS) and Sypris Solutions (SYPR).

Who are Danaher's key executives?

Danaher's management team includes the folowing people:

Mr. Thomas P. Joyce Jr., CEO, Pres & Director (Age 57)
Mr. Daniel L. Comas, CFO & Exec. VP (Age 54)
Ms. Angela S. Lalor, Sr. VP of HR (Age 53)
Mr. William K. Daniel II, Exec. VP (Age 53)
Mr. Rainer M. Blair, Exec. VP (Age 54)

Has Danaher been receiving favorable news coverage?

Press coverage about DHR stock has been trending somewhat positive on Thursday, according to Accern. Accern rates the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Danaher earned a media sentiment score of 0.02 on Accern's scale. They also assigned news headlines about the conglomerate an impact score of 46.83 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are Danaher's major shareholders?

Danaher's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.23%), Massachusetts Financial Services Co. MA (3.07%), Northern Trust Corp (1.30%), Flossbach Von Storch AG (0.80%), Aristotle Capital Management LLC (0.64%) and Dimensional Fund Advisors LP (0.58%). Company insiders that own Danaher stock include Angela S Lalor, Brian W Ellis, Brijender (Binny) Jass Jassal, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Institutional Ownership Trends for Danaher.

Which institutional investors are selling Danaher stock?

DHR stock was sold by a variety of institutional investors in the last quarter, including Flossbach Von Storch AG, Westfield Capital Management Co. LP, Federated Investors Inc. PA, Findlay Park Partners LLP, JPMorgan Chase & Co., Dimensional Fund Advisors LP, Honeywell International Inc. and Legal & General Group Plc. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Insider Buying and Selling for Danaher.

Which institutional investors are buying Danaher stock?

DHR stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Schroder Investment Management Group, Millennium Management LLC, Amundi Pioneer Asset Management Inc., Summit Trail Advisors LLC, Eaton Vance Management, Baird Financial Group Inc. and Schwab Charles Investment Management Inc.. Company insiders that have bought Danaher stock in the last two years include Brijender (Binny) Jass Jassal and Donald J Ehrlich. View Insider Buying and Selling for Danaher.

How do I buy shares of Danaher?

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $102.29.

How big of a company is Danaher?

Danaher has a market capitalization of $70.84 billion and generates $18.33 billion in revenue each year. The conglomerate earns $2.49 billion in net income (profit) each year or $4.03 on an earnings per share basis. Danaher employs 67,000 workers across the globe.

How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]

MarketBeat Community Rating for Danaher (DHR)

Community Ranking:		3.3 out of 5 ( )
Outperform Votes:		752 (Vote Outperform)
Underperform Votes:		400 (Vote Underperform)
Total Votes:		1,152

MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote "Outperform" if you believe DHR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DHR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Danaher (NYSE:DHR) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

17 Wall Street analysts have issued ratings and price targets for Danaher in the last 12 months. Their average twelve-month price target is $105.0647, suggesting that the stock has a possible upside of 2.71%. The high price target for DHR is $117.00 and the low price target for DHR is $83.00. There are currently 4 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.76	2.76	2.79	2.75
Ratings Breakdown:	0 Sell Rating(s) 4 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 4 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 4 Hold Rating(s) 15 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 4 Hold Rating(s) 12 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$105.0647	$105.0647	$101.3106	$92.9615
Price Target Upside:	2.71% upside	3.87% upside	5.42% upside	2.39% upside

Danaher (NYSE:DHR) Consensus Price Target History

Price Target History for Danaher (NYSE:DHR)

Danaher (NYSE:DHR) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/20/2018	Barclays	Reiterated Rating	Buy	$113.00	Low
4/20/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$112.00 ➝ $113.00	Low
4/20/2018	Jefferies Group	Reiterated Rating	Buy	$117.00	Low
4/20/2018	Robert W. Baird	Reiterated Rating	Buy	$106.00	Low
4/19/2018	Stifel Nicolaus	Reiterated Rating	Buy ➝ Buy	$108.00 ➝ $114.00	Low
3/13/2018	Credit Suisse Group	Boost Price Target	Outperform ➝ Outperform	$106.00 ➝ $108.00	Low
3/1/2018	Deutsche Bank	Lower Price Target	Buy ➝ Buy	$114.00 ➝ $107.00	Low
2/1/2018	Argus	Boost Price Target	Buy	$100.00 ➝ $115.00	Low
1/31/2018	Royal Bank of Canada	Reiterated Rating	Hold	$98.00	Low
1/30/2018	Cowen	Reiterated Rating	Buy	$110.00	Low
1/22/2018	UBS	Initiated Coverage	Buy	$116.00 ➝ $99.97	Low
1/3/2018	Evercore ISI	Initiated Coverage	Outperform		Low
12/15/2017	Citigroup	Boost Price Target	Buy	$107.00	High
9/26/2017	Goldman Sachs Group	Reiterated Rating	Neutral ➝ Neutral	$83.00	Low
9/8/2017	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$95.00	Low
7/22/2017	Wells Fargo & Co	Reiterated Rating	Market Perform		Low
6/7/2017	Janney Montgomery Scott	Downgrade	Buy ➝ Neutral		Low
4/23/2017	William Blair	Reiterated Rating	Outperform		Low
4/23/2017	BTIG Research	Reiterated Rating	Buy	$92.00	Low
12/15/2016	Sanford C. Bernstein	Reiterated Rating	Outperform		N/A
5/29/2016	Bank of America	Reiterated Rating	Buy		N/A

(Data available from 5/24/2016 forward)

Danaher (NYSE:DHR) Earnings History and Estimates Chart

Earnings by Quarter for Danaher (NYSE:DHR)

Danaher (NYSE:DHR) Earnings Estimates

2018 EPS Consensus Estimate: $4.37
2019 EPS Consensus Estimate: $4.84

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	2	$0.92	$0.94	$0.93
Q2 2018	2	$1.08	$1.10	$1.09
Q3 2018	2	$1.06	$1.07	$1.07
Q4 2018	2	$1.27	$1.30	$1.29
Q1 2019	1	$1.13	$1.13	$1.13
Q2 2019	1	$1.19	$1.19	$1.19
Q3 2019	1	$1.19	$1.19	$1.19
Q4 2019	1	$1.33	$1.33	$1.33

Danaher (NYSE DHR) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/18/2018		$1.09					N/A
4/19/2018	Q1 2018	$0.94	$0.99	$4.5430 billion	$4.6954 billion	View	N/A
1/30/2018	Q4 2017	$1.16	$1.19	$4.9673 billion	$5.0857 billion	View	Listen
10/19/2017	Q3 2017	$0.95	$1.00	$4.4705 billion	$4.5282 billion	View	N/A
7/20/2017	Q2 2017	$0.97	$0.99	$4.4979 billion	$4.5101 billion	View	N/A
4/20/2017	Q1 2017	$0.84	$0.85	$4.1651 billion	$4.2057 billion	View	N/A
1/31/2017	Q416	$1.03	$1.05	$4.54 billion	$4.60 billion	View	N/A
10/20/2016	Q316	$0.82	$0.87	$4.14 billion	$4.10 billion	View	Listen
7/25/2016	Q216	$1.22	$1.25	$5.76 billion	$5.80 billion	View	Listen
4/21/2016	Q116	$1.03	$1.08	$5.33 billion	$5.39 billion	View	Listen
1/26/2016	Q415	$1.27	$1.27	$6.03 billion	$5.88 billion	View	Listen
10/22/2015	Q315	$1.04	$1.05	$4.99 billion	$5.02 billion	View	Listen
7/23/2015	Q215	$1.04	$1.08	$5.07 billion	$5.1270 billion	View	Listen
4/23/2015	Q115	$0.93	$0.93	$4.84 billion	$4.87 billion	View	Listen
1/27/2015	Q414	$1.04	$1.04	$5.39 billion	$5.42 billion	View	Listen
10/16/2014	Q314	$0.90	$0.90	$4.90 billion	$4.90 billion	View	Listen
7/17/2014	Q214	$0.94	$0.95	$4.97 billion	$5.00 billion	View	Listen
4/16/2014	Q114	$0.80	$0.81	$4.67 billion	$4.6627 billion	View	Listen
1/28/2014	Q413	$0.95	$0.96	$5.20 billion	$5.27 billion	View	Listen
10/17/2013	Q313	$0.83	$0.84	$4.61 billion	$4.67 billion	View	Listen
7/18/2013	Q2 2013	$0.85	$0.87	$4.72 billion	$4.70 billion	View	Listen
4/18/2013	Q1 2013	$0.76	$0.75	$4.50 million	$4.40 million	View	Listen
1/29/2013	Q4 2012	$0.86	$0.89	$4.81 billion	$4.98 billion	View	Listen
10/18/2012		$0.79	$0.77			View	N/A
7/19/2012		$0.80	$0.84			View	N/A
4/19/2012		$0.71	$0.73			View	N/A
1/31/2012		$0.78	$0.81			View	N/A
10/20/2011		$0.70	$0.73			View	N/A
7/21/2011		$0.67	$0.69			View	N/A
4/21/2011		$0.57	$0.65			View	N/A
1/27/2011		$0.66	$0.67			View	N/A
10/21/2010	Q3 2010	$0.55	$0.60			View	N/A
7/22/2010	Q2 2010	$0.53	$0.56			View	N/A
4/22/2010	Q1 2010	$0.44	$0.48			View	N/A
1/28/2010	Q4 2009	$0.50	$0.56			View	N/A
10/22/2009	Q3 2009	$0.43	$0.45			View	N/A
7/23/2009	Q2 2009	$0.43	$0.40			View	N/A
4/23/2009	Q1 2009	$0.37	$0.36			View	N/A
1/26/2009	Q4 2008	$0.52	$0.56			View	N/A
10/16/2008	Q3 2008	$0.57	$0.57			View	N/A
7/17/2008	Q2 2008	$0.53	$0.55			View	N/A
4/17/2008	Q1 2008	$0.44	$0.44			View	N/A
1/24/2008	Q4 2007	$0.56	$0.56			View	N/A

(Earnings results data provided by Zacks Investment Research)

Danaher (NYSE:DHR) Dividend Information

Danaher pays an annual dividend of $0.64 per share, with a dividend yield of 0.63%. DHR's next quarterly dividend payment will be made on Friday, July 27. Danaher pays out 15.88% of its earnings out as a dividend.

Next Dividend:	7/27/2018
Annual Dividend:	$0.64
Dividend Yield:	0.63%
Dividend Growth:	18.80% (3 Year Average)
Payout Ratio(s):	15.88% (Trailing 12 Months of Earnings) 14.38% (Based on This Year's Estimates) 13.28% (Based on Next Year's Estimates) 10.81% (Based on Cash Flow)
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Danaher (NYSE:DHR)

Danaher (NYSE:DHR) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/8/2018	quarterly	$0.16	0.65%	6/28/2018	6/29/2018	7/27/2018
2/20/2018	quarterly	$0.16	0.65%	3/28/2018	3/29/2018	4/27/2018
12/5/2017	quarterly	$0.14	0.61%	12/28/2017	12/29/2017	1/26/2018
9/12/2017	quarterly	$0.14	0.64%	9/28/2017	9/29/2017	10/27/2017
5/9/2017	quarterly	$0.14	0.68%	6/28/2017	6/30/2017	7/28/2017
2/21/2017	quarterly	$0.14	0.66%	3/29/2017	3/31/2017	4/28/2017
12/6/2016	quarterly	$0.1250	0.65%	12/28/2016	12/30/2016	1/27/2017
9/13/2016	quarterly	$0.1250	0.65%	9/28/2016	9/30/2016	10/28/2016
5/10/2016	quarterly	$0.16	0.65%	6/1/2016	6/3/2016	7/29/2016
2/23/2016	quarterly	$0.16	0.73%	3/22/2016	3/25/2016	4/29/2016
12/8/2015	quarterly	$0.1350	0.57%	12/17/2015	12/21/2015	1/29/2016
9/16/2015	quarterly	$0.1350	0.61%	9/23/2015	9/25/2015	10/30/2015
5/18/2015	quarterly	$0.1350	0.62%	6/24/2015	6/26/2015	7/31/2015
2/25/2015	quarterly	$0.1350	0.62%	3/25/2015	3/27/2015	4/24/2015
12/10/2014	quarterly	$0.10	0.48%	12/23/2014	12/26/2014	1/30/2015
9/9/2014	quarterly	$0.10	0.52%	9/24/2014	9/26/2014	10/31/2014
5/8/2014	quarterly	$0.10	0.55%	6/25/2014	6/27/2014	7/25/2014
12/12/2013	quarterly	$0.0250	0.13%	12/26/2013	12/30/2013	1/31/2014
9/12/2013	quarterly	$0.0250	0.14%	9/25/2013	9/27/2013	10/25/2013
5/22/2013	quarterly	$0.0250	0.16%	6/26/2013	6/28/2013	7/26/2013
2/22/2013	quarterly	$0.0250	0.16%	3/26/2013	3/28/2013	4/26/2013

(Data available from 1/1/2013 forward)

Danaher (NYSE DHR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 11.90%
Institutional Ownership Percentage: 76.66%

Insider Trading History for Danaher (NYSE:DHR)

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Danaher (NYSE DHR) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/26/2018	Linda P Hefner	Director	Sell	18,001	$101.51	$1,827,281.51	25,225
4/23/2018	Daniel L Comas	CFO	Sell	78,379	$101.67	$7,968,792.93	148,769
4/20/2018	Daniel L Comas	CFO	Sell	25,206	$101.39	$2,555,636.34	148,769
4/20/2018	Thomas Patrick Joyce Jr	Insider	Sell	120,354	$101.17	$12,176,214.18	151,959
2/26/2018	John T Schwieters	Director	Sell	10,578	$100.30	$1,060,973.40	29,531
2/26/2018	Rainer Blair	Insider	Sell	3,981	$100.05	$398,299.05	49,751
2/23/2018	Walter G Lohr	Director	Sell	10,578	$97.90	$1,035,586.20	19,821
2/21/2018	Rainer Blair	Insider	Sell	51,080	$97.26	$4,968,040.80	50,477
2/2/2018	Angela S Lalor	SVP	Sell	42,988	$102.29	$4,397,242.52	82,008
2/2/2018	William K Daniel	EVP	Sell	131,066	$102.05	$13,375,285.30	270,523
2/1/2018	Daniel L Comas	CFO	Sell	62,989	$101.96	$6,422,358.44	227,805
11/16/2017	Daniel Raskas	SVP	Sell	37,870	$93.33	$3,534,407.10
11/1/2017	Thomas Patrick Joyce Jr	CEO	Sell	125,989	$92.64	$11,671,620.96	271,737
10/24/2017	Donald J Ehrlich	Director	Sell	10,578	$90.82	$960,693.96	104,621
10/23/2017	Daniel L Comas	CFO	Sell	88,184	$91.02	$8,026,507.68	227,816
10/23/2017	Robert S Lutz	CAO	Sell	11,189	$91.66	$1,025,583.74	18,314
8/31/2017	William King	Insider	Sell	43,688	$82.86	$3,619,987.68	45,748
7/31/2017	Thomas Patrick Joyce Jr	Insider	Sell	9,772	$81.78	$799,154.16	155,520
7/21/2017	Linda P Hefner	Director	Sell	10,578	$83.03	$878,291.34	42,151
7/21/2017	William King	Insider	Sell	7,458	$82.97	$618,790.26	18,245
5/23/2017	Angela S Lalor	SVP	Sell	10,815	$84.16	$910,190.40	39,020
4/25/2017	William K Daniel	EVP	Sell	17,444	$83.07	$1,449,073.08	132,995
4/21/2017	Donald J Ehrlich	Director	Buy	600	$82.76	$49,656.00	84,800
4/21/2017	Thomas Patrick Joyce Jr	Insider	Sell	54,006	$82.52	$4,456,575.12	142,157
2/28/2017	Brian W Ellis	Insider	Sell	983	$86.00	$84,538.00	6,174
2/24/2017	Robert S Lutz	SVP	Sell	37,870	$85.60	$3,241,672.00	27,475
2/15/2017	Walter G Lohr	Director	Sell	10,578	$84.32	$891,936.96	18,831
2/14/2017	Donald J Ehrlich	Director	Sell	10,578	$83.98	$888,340.44	95,378
1/13/2017	Brijender (Binny) Jass Jassal	Insider	Sell	437,667	$0.03	$13,130.01
12/8/2016	Brijender (Binny) Jass Jassal	Insider	Sell	63,000	$0.03	$1,890.00
12/5/2016	Brijender (Binny) Jass Jassal	Insider	Buy	100,000	$0.03	$3,000.00
10/21/2016	Thomas Patrick Joyce Jr	Insider	Sell	36,125	$79.68	$2,878,440.00	205,407
8/1/2016	Thomas Patrick Joyce Jr	Insider	Sell	45,897	$81.44	$3,737,851.68	179,054
7/27/2016	Daniel L Comas	CFO	Sell	96,446	$80.88	$7,800,552.48	215,716
5/12/2016	Angela S Lalor	SVP	Sell	8,392	$97.77	$820,485.84	48,110
4/27/2016	James A Lico	EVP	Sell	58,954	$96.93	$5,714,411.22	181,517
4/22/2016	Daniel L Comas	CFO	Sell	89,280	$95.71	$8,544,988.80	230,978
4/22/2016	Thomas Patrick Joyce Jr	CEO	Sell	14,630	$95.50	$1,397,165.00	137,246
4/22/2016	William K Daniel	EVP	Sell	41,140	$96.06	$3,951,908.40	164,785
4/22/2016	William King	SVP	Sell	6,000	$96.31	$577,860.00	17,386
2/29/2016	James A Lico	EVP	Sell	60,000	$89.24	$5,354,400.00	186,878
2/26/2016	Daniel Raskas	SVP	Sell	4,656	$89.00	$414,384.00	17,786
2/26/2016	Walter G Lohr	Director	Sell	8,000	$89.06	$712,480.00	461,505
2/10/2016	Donald J. Ehrlich	Director	Sell	8,000	$86.00	$688,000.00	69,905
1/27/2016	Thomas Patrick Joyce, Jr.	CEO	Sell	25,300	$83.98	$2,124,694.00	115,823
11/24/2015	James A. Lico	EVP	Sell	55,840	$96.40	$5,382,976.00	135,405
10/30/2015	William K. Daniel	EVP	Sell	39,740	$93.04	$3,697,409.60	97,950
10/23/2015	Daniel L. Comas	CFO	Sell	36,200	$92.71	$3,356,102.00	99,798
10/23/2015	Robert S. Lutz	CAO	Sell	26,400	$93.45	$2,467,080.00	16,092
10/23/2015	Thomas Patrick Joyce, Jr.	CEO	Sell	25,300	$93.47	$2,364,791.00	115,823
7/24/2015	Thomas Patrick Joyce Jr	CEO	Sell	25,300	$88.20	$2,231,460.00
7/24/2015	William K Daniel	EVP	Sell	15,000	$88.40	$1,326,000.00
7/24/2015	William King	SVP	Sell	4,000	$88.00	$352,000.00
5/28/2015	Angela S Lalor	SVP	Sell	5,959	$87.06	$518,790.54
5/22/2015	Walter G Lohr	Director	Sell	8,000	$87.00	$696,000.00
5/19/2015	Jonathan P Graham	VP	Sell	30,232	$86.89	$2,626,858.48
5/15/2015	Jonathan P Graham	VP	Sell	185,620	$87.73	$16,284,442.60
4/24/2015	Daniel L Comas	CFO	Sell	25,000	$83.50	$2,087,500.00
4/24/2015	Thomas Patrick Joyce Jr	CEO	Sell	43,945	$83.81	$3,683,030.45
4/24/2015	William K Daniel	EVP	Sell	58,400	$83.33	$4,866,472.00
2/26/2015	Daniel Raskas	SVP	Sell	4,179	$87.79	$366,874.41
2/24/2015	Jonathan P Graham	VP	Sell	9,961	$86.77	$864,315.97
2/20/2015	Daniel Raskas	SVP	Sell	56,000	$87.03	$4,873,680.00
2/3/2015	Donald J Ehrlich	Director	Sell	8,000	$84.82	$678,560.00
2/2/2015	James A Lico	EVP	Sell	98,000	$82.64	$8,098,720.00
2/2/2015	Walter G Lohr	Director	Sell	8,000	$82.30	$658,400.00
1/28/2015	Daniel L Comas	CFO	Sell	75,000	$84.59	$6,344,250.00
11/20/2014	James H Ditkoff	VP	Sell	3,606	$82.35	$296,954.10
11/3/2014	Thomas Patrick Joyce Jr	CEO	Sell	50,000	$79.97	$3,998,500.00
10/29/2014	Angela S Lalor	SVP	Sell	8,450	$79.45	$671,352.50
8/1/2014	William King	SVP	Sell	3,545	$73.74	$261,408.30
7/18/2014	H Lawrence Culp Jr	CEO	Sell	111,540	$74.14	$8,269,575.60
5/28/2014	John T Schwieters	Director	Sell	8,000	$78.73	$629,840.00
5/12/2014	Jonathan Graham	VP	Sell	9,973	$75.00	$747,975.00	31,569
5/1/2014	Daniel Raskas	SVP	Sell	11,158	$73.48	$819,889.84	18,368
2/25/2014	Robert Lutz	CAO	Sell	6,250	$76.85	$480,312.50	18,367
10/24/2013	Daniel L Comas	CFO	Sell	50,000	$71.65	$3,582,500.00
10/18/2013	Daniel Raskas	SVP	Sell	20,000	$71.99	$1,439,800.00
8/29/2013	Donald Ehrlich	Director	Sell	8,000	$65.25	$522,000.00	87,700
8/6/2013	Thomas Patrick Joyce, Jr.	EVP	Sell	48,000	$67.04	$3,217,920.00	124,211
7/24/2013	Daniel Raskas	SVP	Sell	20,000	$67.54	$1,350,800.00
7/22/2013	Daniel L Comas	CFO	Sell	54,540	$68.14	$3,716,355.60
7/19/2013	Robert S Lutz	CAO	Sell	5,852	$68.57	$401,271.64
7/1/2013	James A Lico	EVP	Sell	50,000	$64.66	$3,233,000.00
5/21/2013	Daniel L Comas	CFO	Sell	55,000	$63.89	$3,513,950.00
5/16/2013	Walter G Lohr	Director	Sell	8,000	$62.72	$501,760.00
5/15/2013	H Lawrence Culp Jr	CEO	Sell	500,000	$61.92	$30,960,000.00
5/13/2013	James A Lico	EVP	Sell	22,519	$61.75	$1,390,548.25
2/25/2013	Jonathan P Graham	VP	Sell	7,295	$61.38	$447,767.10
2/25/2013	Thomas Patrick Joyce Jr	EVP	Sell	20,723	$61.24	$1,269,076.52

(Data available from 1/1/2013 forward)

Danaher (NYSE DHR) News Headlines

Source:

Date	Headline
	Danaher To Present At Bernstein Strategic Decisions Conference finance.yahoo.com - May 24 at 5:38 PM
	Form SD DANAHER CORP /DE/ www.streetinsider.com - May 21 at 5:08 PM
	Analyzing Orbotech (ORBK) & Danaher (DHR) www.americanbankingnews.com - May 20 at 3:21 PM
	Reviewing Danaher (DHR) & Rudolph Technologies (RTEC) www.americanbankingnews.com - May 19 at 7:18 PM
	Analysts Expect Danaher Co. (DHR) Will Post Quarterly Sales of $4.92 Billion www.americanbankingnews.com - May 19 at 2:10 AM
	$1.09 Earnings Per Share Expected for Danaher Co. (DHR) This Quarter www.americanbankingnews.com - May 17 at 9:14 PM
	Danaher (DHR) Rating Increased to Buy at Zacks Investment Research www.americanbankingnews.com - May 17 at 3:09 PM
	Fortive (FTV) vs. Danaher (DHR) Financial Contrast www.americanbankingnews.com - May 17 at 1:22 AM
	Zacks Investment Research Downgrades Danaher (DHR) to Hold www.americanbankingnews.com - May 16 at 1:35 PM
	Danaher and Three More Machinery Stocks on Our Research Desk Radar finance.yahoo.com - May 14 at 8:32 AM
	Global Point-of-Care Coagulation Testing Market 2018-2022: Key Vendors are Abbott, Danaher, F. Hoffmann-La ... www.prnewswire.com - May 11 at 5:53 PM
	Danaher Co. (DHR) Receives Average Rating of "Buy" from Analysts www.americanbankingnews.com - May 10 at 5:45 PM
	Danaher Co. (DHR) Plans Quarterly Dividend of $0.16 www.americanbankingnews.com - May 8 at 5:35 PM
	Report: Developing Opportunities within Cboe Global Markets, Colgate-Palmolive, Conduent, Danaher, Jacobs ... globenewswire.com - May 8 at 8:19 AM
	Danaher to Present at Bank of America Merrill Lynch Health Care Conference finance.yahoo.com - May 7 at 5:35 PM
	Critical Review: Sensata Technologies (ST) and Danaher (DHR) www.americanbankingnews.com - May 6 at 5:25 PM
	Charts Say Danaher Could Rally Some 50% From Here finance.yahoo.com - May 4 at 8:22 AM
	Free Research Report as Danaher’s Quarterly Revenues Jumped 11.5%; Adjusted EPS Advanced 16.5% finance.yahoo.com - May 3 at 8:19 AM
	Danaher Co. (DHR) Expected to Post Quarterly Sales of $4.92 Billion www.americanbankingnews.com - May 2 at 4:16 AM
	Beckman Coulter Launches the DxH 900 Hematology Analyzer finance.yahoo.com - May 1 at 5:16 PM
	Insider Selling: Danaher Co. (DHR) Director Sells 18,001 Shares of Stock www.americanbankingnews.com - April 30 at 7:26 PM
	Zacks: Analysts Expect Danaher Co. (DHR) Will Post Earnings of $1.09 Per Share www.americanbankingnews.com - April 30 at 9:19 AM
	WSJ: Danaher approached GE about deal for life sciences unit seekingalpha.com - April 25 at 5:45 PM
	BRIEF-Danaher approached GE about deal for GE'S life-sciences unit - WSJ www.reuters.com - April 25 at 5:27 PM
	[$$] Danaher Approached GE About Deal for Life-Sciences Unit finance.yahoo.com - April 25 at 5:27 PM
	Insider Selling: Danaher Co. (DHR) CFO Sells 25,206 Shares of Stock www.americanbankingnews.com - April 24 at 7:32 PM
	Insider Selling: Danaher Co. (DHR) CFO Sells 78,379 Shares of Stock www.americanbankingnews.com - April 24 at 7:32 PM
	Insider Selling: Danaher Co. (DHR) Insider Sells 120,354 Shares of Stock www.americanbankingnews.com - April 24 at 7:32 PM
	Danaher (DHR) vs. Esterline (ESL) Head to Head Contrast www.americanbankingnews.com - April 24 at 3:12 PM
	Thought You Couldn't Buy a Safe Stock With Growth Prospects? Think Again www.fool.com - April 24 at 8:22 AM
	Thought You Couldn't Buy a Safe Stock With Growth Prospects? Think Again finance.yahoo.com - April 24 at 8:22 AM
	Jefferies Group Weighs in on Danaher Co.'s Q2 2018 Earnings (DHR) www.americanbankingnews.com - April 23 at 1:52 AM
	Danaher's Growing Leverage To Life Sciences Improves The Long-Term Outlook seekingalpha.com - April 20 at 5:19 PM
	Danaher's (DHR) CEO Tom Joyce on Q1 2018 Results - Earnings Call Transcript seekingalpha.com - April 20 at 5:19 PM
	Danaher (DHR) Rating Reiterated by Barclays www.americanbankingnews.com - April 20 at 1:19 PM
	Morgan Stanley Raises Danaher (DHR) Price Target to $113.00 www.americanbankingnews.com - April 20 at 10:25 AM
	Jefferies Group Reaffirms "Buy" Rating for Danaher (DHR) www.americanbankingnews.com - April 20 at 9:28 AM
	Danaher (DHR) Given "Buy" Rating at Robert W. Baird www.americanbankingnews.com - April 20 at 7:46 AM
	Contrasting Danaher (DHR) & Sensata Technologies (ST) www.americanbankingnews.com - April 20 at 5:25 AM
	Danaher's (DHR) "Buy" Rating Reaffirmed at Stifel Nicolaus www.americanbankingnews.com - April 19 at 9:40 PM
	Danaher Corporation (DHR) Q1 2018 Earnings Conference Call Transcript www.fool.com - April 19 at 5:35 PM
	Danaher Corporation 2018 Q1 - Results - Earnings Call Slides seekingalpha.com - April 19 at 5:35 PM
	Danaher (DHR) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS www.americanbankingnews.com - April 19 at 9:27 AM
	Danaher (DHR) Releases Q2 Earnings Guidance www.americanbankingnews.com - April 19 at 9:10 AM
	Danaher (DHR) Releases FY18 Earnings Guidance www.americanbankingnews.com - April 19 at 9:10 AM
	Danaher (DHR) Tops Q1 EPS by 5c, Beats on Revenues; Boosts FY18 EPS Mid-Point Outlook Above Consensus www.streetinsider.com - April 19 at 8:19 AM
	BRIEF-Danaher Reports Q1 Adjusted Non-Gaap Earnings Per Share $0.99 www.reuters.com - April 19 at 8:19 AM
	Danaher Reports First Quarter 2018 Results finance.yahoo.com - April 19 at 8:19 AM
	Danaher Corporation to Host Earnings Call finance.yahoo.com - April 19 at 8:19 AM
	Danaher: 1Q Earnings Snapshot finance.yahoo.com - April 19 at 8:19 AM

Danaher (NYSE:DHR) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Danaher (NYSE:DHR) Income Statement, Balance Sheet and Cash Flow Statement

Danaher (NYSE DHR) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff